I got a DVM degree from the Veterinary School of the National University of Uruguay, followed by one-year training in Pathology from Uppsala University (Sweden), one masters and one PhD degree in Immunology from Cornell, as well as another PhD from Cornell in Methodological Sciences. Then I worked in bovine medicine (Cornell, North Carolina State Univ.) and, in 2001, I published the first experimental, controlled, and longitudinal study on immuno-bacterial interactions (induced by S. Aureus) conducted in mammals. That was the first paper that reported some new metrics (such as the neutrophil/lymphocyte ratio) can inform earlier on how inflammation occurs and evolves over time (https://pubmed.ncbi.nlm.nih.gov/11580061/ ). The 2001 paper opened the path that brings us to the present and relates to human medicine (both at UNM and internationally). After becoming familiar with Prof. Marc Van Regenmortel's writings on the limitations of reductionism and publishing about it (https://www.frontiersin.org/articles/10.3389/fimmu.2017.00612/full), we started to develop, first, the theory and, more recently, the operations (software and cell phone apps) required to materialize a method that informs more or better, earlier, which, hopefully, could one day be operated by every clinician.